Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Touijer

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
ACS Applied Materials & Interfaces|November 2, 2019
Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate CancerFeng Chen, Kai Ma, Li Zhang, et al.
The Journal of Urology|April 1, 2022
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerMarlon Perera, Melissa J Assel, Nicole E Benfante, et al.
BJU International|February 17, 2015
Preoperative predictive model of recovery of urinary continence after radical prostatectomyKazuhito Matsushita, Matthew T Kent, Andrew J Vickers, et al.
World Journal of Urology|June 21, 2025
Local anesthesia for transperineal prostate biopsy performed under sedation: effects on intraoperative and postoperative narcotic useThomas Li, Taylor M McCready, Sunny Nalavenkata, et al.
BJU International|May 1, 2026
Diagnostic and prognostic utility of PSMA-PET/CT in node-metastatic prostate cancerNicholas A Pickersgill, Rebecca Yu, Emily A Vertosick, et al.
Urology Practice|June 20, 2020
Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical ProstatectomyGregory T Chesnut, Nicole Benfante, David Barham, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Cancer|November 1, 2021
Have urinary function outcomes after radical prostatectomy improved over the past decade?Matthew B Clements, Caroline C Gmelich, Emily A Vertosick, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Urology Focus|December 24, 2022
Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active SurveillanceMarlon Perera, Ghalib Jibara, Amy L Tin, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
ACS Applied Materials & Interfaces|November 2, 2019
Ultrasmall Renally Clearable Silica Nanoparticles Target Prostate CancerFeng Chen, Kai Ma, Li Zhang, et al.
The Journal of Urology|April 1, 2022
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerMarlon Perera, Melissa J Assel, Nicole E Benfante, et al.
BJU International|February 17, 2015
Preoperative predictive model of recovery of urinary continence after radical prostatectomyKazuhito Matsushita, Matthew T Kent, Andrew J Vickers, et al.
World Journal of Urology|June 21, 2025
Local anesthesia for transperineal prostate biopsy performed under sedation: effects on intraoperative and postoperative narcotic useThomas Li, Taylor M McCready, Sunny Nalavenkata, et al.
BJU International|May 1, 2026
Diagnostic and prognostic utility of PSMA-PET/CT in node-metastatic prostate cancerNicholas A Pickersgill, Rebecca Yu, Emily A Vertosick, et al.
Urology Practice|June 20, 2020
Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical ProstatectomyGregory T Chesnut, Nicole Benfante, David Barham, et al.
Clinical Genitourinary Cancer|September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active SurveillanceMarlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Cancer|November 1, 2021
Have urinary function outcomes after radical prostatectomy improved over the past decade?Matthew B Clements, Caroline C Gmelich, Emily A Vertosick, et al.
Urology Practice|January 28, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management OptionMark T Dawidek, Juan Sebastian Arroyave Villada, Katiana Vazquez-Rivera, et al.
European Urology Focus|December 24, 2022
Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active SurveillanceMarlon Perera, Ghalib Jibara, Amy L Tin, et al.
Pageof 8